mNSCLC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
mNSCLC
Jul 22, 2024, 02:04 |
Blog
Oncology Brothers: A discussion with Balazs Halmos for mNSCLC with actionable mutations in 1L
Oncology Brothers shared a post on X: "Lung Series: This is the Algorithm we have…
Jun 1, 2024, 12:55 |
Societies
Day 1 ASCO24 Highlights by Oncology Brothers
Oncology Brothers shared on X: Day 1 ASCO24 Highlights: 1. CROWN: Lorlatinib in ALK mNSCLC…
May 29, 2024, 12:03 |
Insight
Eric Singhi: MARIPOSA a path forward to help us determine who benefits from 1L combination therapy?
Eric Singhi shared on X: "MARIPOSA: Amivantamab + lazertinib v osimertinib in 1L EGFR+ mNSCLC:…
May 29, 2024, 09:22 |
Blog
Eric K. Singhi: Isn’t it about time we stopped saying that "patients failed treatment"
Eric K. Singhi reshared his previous post on X and added: ; "But…
May 19, 2024, 05:29 |
Blog
Eric Singhi: With FLAURAishing new frontline combination therapies for EGFR and metastatic NSCLC yet incomplete data
Eric Singhi shared on X: "With FLAURAishing new frontline combination therapies for EGFR and metastatic…
May 7, 2024, 23:04 |
Insight
Eric K. Singhi: Our new Clinical Lung Brief Report on 1L testing & management in mNSCLC
Eric K. Singhi shared the following on X: “Our new Clinical Lung Brief Report on…
May 2, 2024, 23:45 |
Insight
Aakash Desai: Insights into mNSCLC Management through a Global Clinician Survey
Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared a post on…
Mar 5, 2024, 19:49 |
Insight
Eric K. Singhi: Great to see this option approved for our patients with Exon 20 Group insertions
Eric K. Singhi, Thoracic Medical Oncologist and Assistant Professor at the MD Anderson Cancer Center,…
Jan 10, 2024, 11:54 |
Societies
ESMO Guideline: Oncogene-Addicted mNSCLC - The European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) posted on X/Twitter: "ESMO Guideline: Oncogene-Addicted mNSCLC. Developed…
All:
9
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube